← Back
Data updated: Mar 10, 2026
SUN PHARMA GLOBAL
ImmunologyOncologyNeurology
SUN PHARMA GLOBAL is a pharmaceutical company focused on Immunology, Oncology, Neurology. Key products include ZOLEDRONIC ACID.
2008
Since
8
Drugs
-
Trials
87
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
ARIPIPRAZOLE 2026-02-18
ZOLEDRONIC ACID 2026-02-05
SITAGLIPTIN PHOSPHATE 2026-01-20
SITAGLIPTIN PHOSPHATE 2026-01-14
SITAGLIPTIN PHOSPHATE 2025-12-29
ILUMYA 2025-12-12
Efficacy
ARIPIPRAZOLE 2025-11-14
Labeling
ARIPIPRAZOLE 2025-11-14
Labeling
ARIPIPRAZOLE 2025-11-14
Labeling
ARIPIPRAZOLE 2025-11-14
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
Immunology 33%
1 drugs
Oncology 33%
1 drugs
Neurology 33%
1 drugs
Pipeline Strength Pro
Loading...
Discontinued (2)
Company Info
- First Approval
- 2008-04-21
- Latest
- 2025-12-12
- Applications
- 13